DCDC2B Activators
Chemical activators of DCDC2B function by modulating the cellular levels of cyclic AMP (cAMP), a critical secondary messenger that facilitates the activation of protein kinase A (PKA). Forskolin, a potent activator of adenylate cyclase, directly increases the production of cAMP within the cell. This rise in cAMP levels leads to the activation of PKA, which is capable of phosphorylating DCDC2B, thereby enhancing its function. Similarly, agents such as Isoproterenol and Epinephrine operate through beta-adrenergic receptors to stimulate adenylate cyclase, culminating in elevated cAMP and subsequent PKA activation. PKA then targets proteins like DCDC2B for phosphorylation. Anagrelide and IBMX, though through different mechanisms, also elevate cAMP levels; Anagrelide inhibits phosphodiesterase III (PDE3), and IBMX is a broad inhibitor of phosphodiesterases, preventing cAMP degradation, which in turn sustains the activation of PKA. Rolipram specifically inhibits phosphodiesterase 4 (PDE4), another enzyme responsible for cAMP breakdown, thus facilitating prolonged PKA activation and phosphorylation of DCDC2B.
Additional compounds such as Parathyroid hormone fragment (1-34), Glucagon, and Luteinizing Hormone Releasing Hormone engage their respective receptors that are linked to the activation of adenylate cyclase, again leading to increased cAMP and PKA activation. PKA, once activated, phosphorylates DCDC2B. Dobutamine, by acting as a beta-adrenergic agonist, and Histamine, through H2 receptors, both promote the production of cAMP leading to the activation of PKA. Prostaglandin E2 (PGE2) likewise interacts with EP receptors, resulting in increased cAMP and PKA-mediated phosphorylation of DCDC2B. The collective action of these chemical activators converges on the pathway involving cAMP production and PKA activation, which are central to the regulation of DCDC2B activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, resulting in increased production of cyclic AMP (cAMP), a secondary messenger that activates cAMP-dependent protein kinase A (PKA). PKA can phosphorylate and thereby activate proteins, including DCDC2B, which could lead to enhanced protein function. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic beta-adrenergic agonist that increases intracellular levels of cAMP by activating adenylate cyclase. The rise in cAMP activates PKA, which in turn can phosphorylate target proteins like DCDC2B, leading to their activation. | ||||||
Parathyroid hormone fragment (1-34) | 52232-67-4 | sc-487943 | 100 µg | $185.00 | ||
Parathyroid hormone fragment (1-34), also known as teriparatide, is a fragment of parathyroid hormone that activates the PTH receptor, leading to increased cAMP production. The resulting PKA activation can phosphorylate and activate DCDC2B. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases that prevents cAMP degradation, leading to elevated cAMP levels in the cell and subsequent activation of PKA. PKA then may phosphorylate DCDC2B, enhancing its activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which metabolizes cAMP. By inhibiting PDE4, rolipram maintains high cAMP levels, which activates PKA. PKA can phosphorylate multiple substrates, including DCDC2B, leading to its activation. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide inhibits phosphodiesterase III (PDE3), which increases cAMP levels within the cell. Elevated cAMP activates PKA, which can subsequently phosphorylate and activate DCDC2B. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages beta-adrenergic receptors, which in turn activate adenylate cyclase and increase intracellular cAMP levels. The increase in cAMP activates PKA, which can phosphorylate and activate DCDC2B. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Dobutamine is a beta-adrenergic agonist that can lead to increased cAMP levels in cells by activating adenylate cyclase. The cAMP then activates PKA, which phosphorylates and activates proteins, potentially including DCDC2B. | ||||||
Glucagon trifluoroacetic acid salt | 9007-92-5 (free base) | sc-495801 | 1 mg | $480.00 | ||
Glucagon interacts with its receptor to stimulate adenylate cyclase, raising intracellular cAMP levels and activating PKA. Activated PKA can catalyze the phosphorylation of proteins like DCDC2B, resulting in their activation. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to H2 receptors, which are positively coupled to adenylate cyclase, resulting in an increase in cAMP and activation of PKA. PKA can then phosphorylate and activate DCDC2B. | ||||||